Leyla Blue prescribes undo riffs for ears (What) damn, hey Leyla Blue
The upcoming
sections will look at the evidence considering different indicators to
explore how the synthetic drugs market changed between 2008/2009 and
2017/18.FIG.
2: Global ATS seizuresSource: UNODC Database, 2019.Note:
Global ATS seizures involve seizures of methamphetamine, amphetamine,
ecstasy-type substances („XTC“), non-specified ATS and other
stimulants.REGIONAL DISTRIBUTION OF GLOBAL QUANTITIES SEIZED, 2008 AND
2017 (TONS)GLOBAL QUANTITIES SEIZED PER DRUG, 2008 AND 2017
(PERCENTAGEsince been spreading to Cyprus, Germany, Spain, Finland and
Nor-way.6Crystalline methamphetamineStrong increases in quantities of
crystalline methamphetamine seized, which is associated with a high
level of health risk for users, point to growing trafficking of the drug
to East and South-East Asia, Oceania and North America.7 In East and
South-East Asia alone, seizures of crystalline metham-phetamine almost
quintupled from 8 tons in 2008 to 39 tons in 2017.8Map 1 shows the
perceived crystal-line methamphetamine trafficking flows in the region
from 2016 to 2018.ManufactureClandestine manufacture of methamphetamine
can range from small-scale kitchen labora-tories to reach the local
markets, to large-scale laboratories with sophisticated manufacturing
equipment using a range of pre-cursor chemicals and synthesis routes
(see photos on page 6). (494)
Global SMART Update, Volume
22.About the SMART UpdateThe ATS market − 10 years after the 32009 Plan
of ActionIntroduction 3General features of the ATS market 3Changes in
the ATS market over time 3Methamphetamine 4Seizures and trafficking
flows 4Manufacture 5Retail prices & purity 6Income & retail
price trends 6Amphetamine 7Seizures and trafficking flows 7Manufacture
7Retail prices & purity 8Ecstasy-type substances 8Seizures and
trafficking flows 8Manufacture 9Retail prices & purity 9ATS
Precursors 9The demand-side of ATS 10Methamphetamine use 10Amphetamine
use 11Ecstasy-type substances use 12Conclusion 13SMART responses to the
synthetic 14drugs problemContent 3Volume 22IntroductionAlready in 1998,
the General Assembly realized that synthetic drugs, at that time mainly
amphet-amine-type stimulants (ATS), were a game changer in a world long
dominated by plant-based drugs such as cannabis, cocaine and heroin.1 In
a globalized and increas-ingly interconnected world, new forms of
information technology such as the Internet contributed to a rapid
spread of knowledge on precursor chemicals and manufac-turing techniques
of ATS as well as on their psychoactive effects and possible forms of
use. (349)
Global SMART Update, Volume 20.Methamphetamine The
fastest growing synthetic drugs market over the past 10 years Seizures
and trafficking flowsSubstantial increases in regional and global
methamphetamine seizures were reported over time, with global seizures
growing more than sevenfold from 25 tons in 2008 to 185 tons in 2017
(see Figure 3). (282)
1: Features of the synthetic drugs
marketSource: UNODC elaborationCan be manufactured anywhereSimplicity
and flexibility in produc�onRange of precursor and synthesis routes
4GLOBAL SMART UPDATEprices and increased quality of methamphetamine,
they indicate a dynamic and growing market for methamphetamine.3The
Americas (mainly North Amer-ica) and Asia (mainly East and South-East
Asia) remained the two main hubs for methamphetamine trafficking over
the past 10 years. (265)
cent (15)
2017 (15)
purity (14)
smart (13)
asia (12)
2018 (12)
retail (10)
trends (10)
united (9)
time (9)
tons (9)
substances (9)
south-east (9)
information (8)
prices (8)
seized (8)
report (8)
increased (8)
stimulants (8)
years (8)
east (8)
price (8)
countries (8)
plan (7)
states (7)
2009 (7)
decade (6)
nations (6)
thailand (6)
other (6)
decreased (6)
quantities (6)
world (6)
remained (6)
patterns (5)
figure (5)
precursor (5)
flows (5)
2019 (5)
regional (5)
quantity (5)
(see (5)
growing (5)
reported (5)
europe (5)
illicit (5)
crystalline (5)
typical (5)
2019a (4)
nominal (4)
The
ATS market −10 years after the 2009 Plan of ActionResearch2019GLOBAL
SMART UP DAT EENVOLUME 22OctoberEN 2GLOBAL SMART UPDATESynthetic drugs
constitute one of the most significant drug problems worldwide.
After
cannabis and opi-oids, amphetamine-type stimulants (ATS) are the most
widely used drugs across the globe, with use levels often exceeding
those of heroin and/or cocaine.
Along with ATS, the continued
growth of the new psycho-active substances (NPS) market over the last
years has become a policy challenge and a major interna-tional concern.
A
growing interplay between these new drugs and traditional illicit drug
markets is being observed, and trends on the synthetic drugs market
evolve quickly each year.
The UNODC Global Synthetics
Monitoring: Analyses, Reporting and Trends (SMART) Programme enhances
the capacity of Member States in priority regions to generate, manage,
analyse, report and use synthetic drugs information to design effec-tive
policy and programme interventions.
Launched in September 2008,
the Global SMART Programme provides capacity building to laboratory
personnel, law enforcement and research officers in the Pacific, East
and South-East Asia, South Asia, the Near and Middle East, Africa, Latin
America and the Caribbean; and regularly reviews the global
amphetamine-type stimulants and new psychoactive substances situation.
Its
main products include online drug data collection, situation assessment
reports, regional assessments and the UNODC Early Warning Advisory
(EWA) on NPS.
The EWA is a webportal that offers regular updates
on new psychoactive substances, including trend data on emergence and
persistence, chemical data, supporting documentation on laboratory
analysis and national leg-islative responses (available at: ).
The Global SMART Update (GSU) series is published twice a year in English, Spanish and Russian.
It
provides information on emerging patterns and trends of the global
synthetic drugs market in a concise format.* Past issues have covered
topics such as the global opioid crisis, the dominance of
methamphetamine in the synthetic drugs market, the role of NPS in the
synthetic drugs market, non-medical use of benzodi-azepines and the
fentanyl group of synthetic opioids.
Electronic copies of the
Global SMART Updates and other publications are available at: * The
information and data contained within this report are from the Annual
Report Questionnaire (ARQ) submitted by Member States to UNODC, the
UNODC Early Warning Advisory (EWA) on NPS, offi-cial Government reports,
press releases, scientific journals or incidents confirmed by UNODC
Field Offices.
This report has not been formally edited.
The
contents of this publication do not necessarily reflect the views or
policies of UNODC or contributory organizations and neither do they
imply any endorsement.
Suggested citation: United Nations Office on Drugs and Crime, 2019.
The ATS market ‒ 10 years after the 2009 Plan of Action.
Global
SMART Update, Volume 22.About the SMART UpdateThe ATS market − 10 years
after the 32009 Plan of ActionIntroduction 3General features of the ATS
market 3Changes in the ATS market over time 3Methamphetamine 4Seizures
and trafficking flows 4Manufacture 5Retail prices & purity 6Income
& retail price trends 6Amphetamine 7Seizures and trafficking flows
7Manufacture 7Retail prices & purity 8Ecstasy-type substances
8Seizures and trafficking flows 8Manufacture 9Retail prices & purity
9ATS Precursors 9The demand-side of ATS 10Methamphetamine use
10Amphetamine use 11Ecstasy-type substances use 12Conclusion 13SMART
responses to the synthetic 14drugs problemContent 3Volume
22IntroductionAlready in 1998, the General Assembly realized that
synthetic drugs, at that time mainly amphet-amine-type stimulants (ATS),
were a game changer in a world long dominated by plant-based drugs such
as cannabis, cocaine and heroin.1 In a globalized and increas-ingly
interconnected world, new forms of information technology such as the
Internet contributed to a rapid spread of knowledge on precursor
chemicals and manufac-turing techniques of ATS as well as on their
psychoactive effects and possible forms of use.
A decade later,
in 2009, Member States real-ized that the absence of a global monitoring
mechanism for syn-thetic drugs made it difficult to fully understand
the illicit market for synthetic drugs and its charac-teristics.
As
a consequence, they adopted the Political Declaration and Plan of
Action on international cooperation towards an integrated and balanced
strategy to counter the world drug problem.21 General Assembly, 1998.
Action Plan against illicit manufacture, trafficking and abuse of amphetamine-type stimulants and their precur-sors.
(A
RES/S 20/4), 21 Oct 1998.The UNODC Global SMART Pro-gramme, a global
monitoring mechanism was set-up in the same year and has since
contributed sig-nificantly to improving the quantity and quality of
information avail-able on the illicit synthetic drugs market.
Comparing
the ATS market from 2008/9 to 2017/18 presented in this Global SMART
Update, shows the picture of an increasing illicit synthetic drugs
market, with signs of further expansion.
Did we just not capture
the full dimension and complexity of the synthetic drugs market in
2008/9 due to a lack of monitoring systems, or has it really multiplied
in volume as some indicators suggest? Which-ever assumption we may
consider more likely, the increase in afford-ability, availability and
purity of ATS in combination with more globalized trafficking patterns
and collaboration of international crim-inal organizations across
continents are a reality, drug policy makers, health systems and drug
control agencies need to get prepared for.2 UNODC (United Nations Office
on Drugs and Crime), 2009.
Political Declaration and Plan of
Action on international cooperation towards an integrated and balanced
strategy to counter the world drug problem.
High-level seg-ment Commission on Narcotic Drugs.
Vienna, 11-12 March 2009.
New
York: United Nations.General features of the ATS marketThe synthetic
drugs market is char-acterized by a number of unique features, ranging
from simplicity and flexibility in production to the availability of
various precursor and synthesis routes (see Figure 1).As synthetic drugs
do not depend on the cultivation of plants or cer-tain environmental
conditions, they can be manufactured any-where, from small to large
scale production.
Changes in the ATS market over timeThe ATS market underwent remark-able changes over the last decade.
New
trends appeared, as for instance an increased differentia-tion of the
ways synthetic drugs are sold and consumed (e g powder, tablets,
capsules, crystals), changes in precursors over time, the appearance of
new psychoactive substances (NPS) or the discovery of new ways of
trafficking (e g dark net).
The synthetic drugs market has been expanding over the past 10 years.
The global quantity of ATS seizures increased more than four times, from 60 tons in 2008 to 261 tons in 2017 (see Figure 2).
Methamphetamine
is becoming the primary ATS drug of concern, as quantities of the drug
seized increased more than sevenfold and its global share of all ATS
seizures increased from 41 per cent in 2008 to 71 per cent in 2017.
The
quantity of ecstasy-type substances (herein-after referred to as
ecstasy’) and amphetamine seized, doubled over the same time period.
Observing
the regional shifts over time, the ATS market spread to new regions:
While in 2008 there were almost no seizures reported by Oceania and
Africa, in 2017 they accounted for 4 per cent and 1 per cent of The ATS
market − 10 years after the 2009 Plan of ActionFIG.
1: Features
of the synthetic drugs marketSource: UNODC elaborationCan be
manufactured anywhereSimplicity and flexibility in produc�onRange of
precursor and synthesis routes 4GLOBAL SMART UPDATEprices and increased
quality of methamphetamine, they indicate a dynamic and growing market
for methamphetamine.3The Americas (mainly North Amer-ica) and Asia
(mainly East and South-East Asia) remained the two main hubs for
methamphetamine trafficking over the past 10 years.
In North
America, the largest amount of seizures by weight were reported by the
United States and Mexico; in East and South-East Asia, China and
Thailand were the main hotspots for methamphetamine trafficking.
In
2018, methamphetamine sei-zures in Thailand were 17 times larger than
the combined amount of methamphetamine seized by the whole East- and
South-East Asian region a decade ago.4 Not only is methamphetamine
trafficked extensively between countries within each of those subregions
but also most methamphetamine trafficked globally is destined for those
two subregions.5 Oceania reported major methamphet-amine seizures since
2012 and in 2017 those accounted for 3 per cent of global
methamphetamine seizures.
Europe has a very small share of
global methamphetamine seizures, however quantities seized increased
from 0.3 tons in 2008 to 2.6 tons in 2017.Europe also registered some
intra-regional shifts over the past decade: While in 2008 the largest
amount of seizures were made in Norway, in 2017, France, Ger-many and
Czechia were among the top three seizing countries.
Furthermore, methamphetamine use in 2008 was mostly restricted to Czechia and Slovakia, but has 3 UNODC, 2018a.
World Drug Report 2018.
Vienna: United Nations.
Sales No.
E 18.XI.9.4 UNODC, 2019a.
Synthetic
Drugs in East and South-East Asia: Trends and patterns of
amphetamine-type stimulants and new psychoac-tive substances.
Bangkok.5 UNODC, 2018b.
Methamphetamine con-tinues to dominate synthetic drug markets.
Global
SMART Update, Volume 20.Methamphetamine The fastest growing synthetic
drugs market over the past 10 years Seizures and trafficking
flowsSubstantial increases in regional and global methamphetamine
seizures were reported over time, with global seizures growing more than
sevenfold from 25 tons in 2008 to 185 tons in 2017 (see Figure 3).
While in 2008, only 50 countries reported seizures, this figure increased to 72 countries in 2017.
The increase in seizures are more than just a reflection of more effective law enforcement activities.
Together with falling global ATS seizures respectively.
The
global share in seizures in the Americas and Asia remained quite stable
over time and decreased in Europe by almost half between 2008 and 2017.
Seizures
are a valuable indicator to understand the size of global drug markets,
however other fac-tors have to be considered when looking at the
expansion of the syn-thetic drugs market.
The upcoming sections
will look at the evidence considering different indicators to explore
how the synthetic drugs market changed between 2008/2009 and
2017/18.FIG. 2: Global ATS seizuresSource: UNODC Database, 2019.Note:
Global ATS seizures involve seizures of methamphetamine, amphetamine,
ecstasy-type substances („XTC“), non-specified ATS and other
stimulants.REGIONAL DISTRIBUTION OF GLOBAL QUANTITIES SEIZED, 2008 AND
2017 (TONS)GLOBAL QUANTITIES SEIZED PER DRUG, 2008 AND 2017
(PERCENTAGE)2008Americas30%Asia50%Europe19%Oceania1%Africa
1%Americas36%Asia49%Europe10%Oceania4%2017Amphetamine45%Methamphetamine41%XTC13%Non-specified
ATS1%Amphetamine22%Methamphetamine71%XTC5%Non-specified ATS1%Other
stimulants1%20082017GLOBAL QUANTITY SEIZED:2008201760 tons261 tons
5Volume 22since been spreading to Cyprus, Germany, Spain, Finland and
Nor-way.6Crystalline methamphetamineStrong increases in quantities of
crystalline methamphetamine seized, which is associated with a high
level of health risk for users, point to growing trafficking of the drug
to East and South-East Asia, Oceania and North America.7 In East and
South-East Asia alone, seizures of crystalline metham-phetamine almost
quintupled from 8 tons in 2008 to 39 tons in 2017.8Map 1 shows the
perceived crystal-line methamphetamine trafficking flows in the region
from 2016 to 2018.ManufactureClandestine manufacture of methamphetamine
can range from small-scale kitchen labora-tories to reach the local
markets, to large-scale laboratories with sophisticated manufacturing
equipment using a range of pre-cursor chemicals and synthesis routes
(see photos on page 6).
Usu-ally drug trafficking organizations
attempt to adapt their manufac-turing methods in response to the
national and international control and the efforts of law enforcement
and industry in targeting and pre-venting the diversion of chemicals.
The
trend in precursor chemicals provides important information for a more
comprehensive under-standing of the synthetic drugs market.9 Currently,
available infor-mation suggests that for most methamphetamine
manufacture 6 EMCDDA (European Monitoring Centre for Drugs and Drug
Addiction), 2010.
Annual report 2010: The state of the drugs problem in Europe.
Luxemburg: Publications Office of the European Union and EMCDDA, 2019.
European drug report 2019: Trends and develop-ments.
Luxemburg: Publications Office of the European Union.
7 UNODC, 2018a.8 UNODC, 2019a and UNODC, 2010a.
Asia and the Pacific: Patterns and trends of ampheta-mine-type stimulants and other drugs.
Bangkok.9
UNODC, 2018b.MAP 1: Perceived crystalline methamphetamine trafficking
flows in East and South-East Asia, 2016−2018Source: UNODC elaboration
based on information from responses to ARQ 2016 and 2017; Country
presentations presented at the 2018 SMART Regional Workshop, Chiang Rai,
Thailand, August 2018 and the Mekong Drugs and Precursor Trafficking
Route Analysis workshop, Ho Chi Minh, Viet Nam, April 2018 in UNODC,
2019a.
Note: The boundaries and names shown and the designations
used on the map do not imply official endorsement or acceptance by the
United Nations.Source: UNODC Database, 2019.FIG. 3: Global
methamphetamine seizuresREGIONAL DISTRIBUTION OF METHAMPHETAMINE
QUANTITIES SEIZED, 2008 AND 2017
(PERCENTAGE)2008Americas50%Asia49%Europe1%Americas47%Asia48%Europe2%Oceania3%2017GLOBAL
QUANTITY SEIZED:COUNTRIES REPORTED:200825 tons2017185 tons200850
countries201772 countriesSouth China SeaJava SeaBay of BengalTimor
SeaEast China SeaChinaViet NamMyanmarThailandLao
PDRCambodiaPhilippinesTaiwan Provinceof
ChinaIndonesiaSingaporeBruneiMalaysiaTimor LesteAustraliaRepublicof
KoreaJapanIndia!To New ZealandDemocra�c People’sRepublic of Korea
6GLOBAL SMART UPDATE6in Africa, Asia, Europe and Ocea-nia ephedrine or
pseudoephedrine continues to be used.
While meth-amphetamine in
North America was manufactured using those pre-cursors a decade ago,
nowadays, mostly P 2-P pre-precursors and a number of non-scheduled
chemi-cals are used.
This shift to other precursors over the
past decade seems to have been a consequence of improved controls of
(pseudo)ephedrine in Canada, Mexico and the United States.10 Retail
prices & purityPrice and purity can be used to understand changes in
the avail-ability of drugs.
In a situation, where larger
amounts of a drug enter a country, and demand does not pick up fast
enough, increases 10 UNODC, 2019b.
World Drug Report 2019.
Vienna: United Nations.
Sales No.
E
19.XI.9. For more information on precursors, please see the section
“ATS Precursors” in this issue.in purity/dosage can be expected while
users would still pay the same amount per dose.
A situation where nominal retail prices fall but purity still goes up could indicate a large increase in availability.
Price11
and purity trends in the two core regions of methamphet-amine
trafficking show that while retail prices of the drug decreased over
time in most countries, purity increased or remained stable.
For
instance, in the United States, the price per pure gram decreased 68
per cent from 220 USD in 2008 to 70 USD in 2017, while the purity
doubled from 46 per cent to 93 per cent respectively (see Figure 4).12In
East- and South-East Asia, the typical purity of methamphet-amine
tablets ranged from 15 per cent to 25 per cent and the retail price
showed recently decreasing tendencies in several countries in 11 The
prices from UNODC sources in general refer to typical nominal prices at
retail level (gram prices), e g no adjustments were made for inflation
or purchasing power, if not other-wise indicated.
12 DEA (Drug Enforcement Agency), 2010.
National drug threat assessment 2010, and DEA, 2018.
National drug threat assessment 2018.
the region.
For
instance, in Thai-land the typical nominal retail price for a
methamphetamine pill decreased from a range of 6 USD to 10 USD in 2008
to 3 USD to 5 USD in 2018.
In Thailand, purity of
methamphetamine pills seems to have remained stable, ranging between 10
per cent to 28 per cent in 2009 and 15 per cent to 25 per cent in 2018.
Likewise,
the typical retail price of crystalline methamphetamine decreased in
several countries in the region, including Cambodia, Indonesia, Japan
and Thailand, while the purity remained high.
For instance, in
Thailand the typical nominal retail price for crystalline
meth-amphetamine decreased from 71 USD to 86 USD per gram in 2008 to 41
USD to 61 USD per gram in 2018.
The purity ranges of
crystal-line methamphetamine remained unchanged at around 90 per cent
over this time period.13Income & retail price trendsetter the past
decade, in sev-eral countries monthly average 13 UNODC, 2019a and UNODC,
2011.
Asia and the Pacific: Patterns and trends of ampheta-mine-type stimulants and other drugs.
Bangkok.FIG.
4: Price and purity development of methamphetamine in the United
States, January−March 2008 and January−March 2017Source: DEA, 2010 and
2018.